Elizabeth A. Reap

5.6k total citations · 3 hit papers
62 papers, 4.4k citations indexed

About

Elizabeth A. Reap is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Elizabeth A. Reap has authored 62 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 23 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Elizabeth A. Reap's work include Immunotherapy and Immune Responses (24 papers), T-cell and B-cell Immunology (15 papers) and CAR-T cell therapy research (14 papers). Elizabeth A. Reap is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), T-cell and B-cell Immunology (15 papers) and CAR-T cell therapy research (14 papers). Elizabeth A. Reap collaborates with scholars based in United States, Germany and South Africa. Elizabeth A. Reap's co-authors include Philip L. Cohen, Roberto Caricchio, H. Shelton Earp, Glenn K. Matsushima, Rona S. Scott, Eileen McMahon, Shannon M. Pop, John H. Sampson, James E. Herndon and Luis Sánchez-Pérez and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Elizabeth A. Reap

60 papers receiving 4.3k citations

Hit Papers

Phagocytosis and clearance of apoptotic cells is mediated... 2001 2026 2009 2017 2001 2002 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phagocytosis and clearance of apoptotic cells is mediated by MER
    2001 935 citations Elizabeth A. Reap, Roberto Caricchio et al. profile →
  2. Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase
    2002 506 citations Philip L. Cohen, Roberto Caricchio et al. The Journal of Experimental Medicine profile →
  3. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
    2015 410 citations Duane A. Mitchell, Kristen A. Batich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Reap United States 27 2.8k 1.2k 1.2k 510 446 62 4.4k
Jason A. Hackney United States 29 2.1k 0.7× 1.2k 0.9× 1.7k 1.4× 384 0.8× 257 0.6× 45 4.7k
Hartmut Merz Germany 26 1.7k 0.6× 1.0k 0.8× 1.3k 1.1× 390 0.8× 336 0.8× 119 4.4k
Maria Raffaella Zocchi Italy 45 3.8k 1.3× 1.4k 1.1× 1.6k 1.3× 691 1.4× 321 0.7× 152 6.0k
Fabio Candotti United States 42 2.5k 0.9× 1.7k 1.4× 1.9k 1.5× 743 1.5× 554 1.2× 171 5.9k
Richard J. Bram United States 35 3.2k 1.1× 899 0.7× 2.7k 2.2× 335 0.7× 447 1.0× 76 6.2k
Loise M. Francisco United States 16 5.8k 2.0× 3.3k 2.7× 1.4k 1.2× 245 0.5× 523 1.2× 19 8.0k
Rudolf A. Manz Germany 36 3.7k 1.3× 805 0.6× 1.1k 0.9× 525 1.0× 462 1.0× 77 6.0k
Bonnie Lyons United States 21 1.7k 0.6× 1.1k 0.9× 1.3k 1.1× 373 0.7× 213 0.5× 42 4.1k
Bradley W. McIntyre United States 36 2.6k 0.9× 849 0.7× 1.7k 1.4× 227 0.4× 153 0.3× 100 5.7k
Lucia Gabriele Italy 35 2.5k 0.9× 1.5k 1.2× 1.1k 0.9× 166 0.3× 273 0.6× 74 4.3k

Countries citing papers authored by Elizabeth A. Reap

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Reap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Reap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Reap more than expected).

Fields of papers citing papers by Elizabeth A. Reap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Reap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Reap. The network helps show where Elizabeth A. Reap may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Reap

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Reap. A scholar is included among the top collaborators of Elizabeth A. Reap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Reap. Elizabeth A. Reap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thompson, Eric M., David M. Ashley, Pamela K. Norberg, et al.. (2024). Outcomes and immune response after peptide vaccination targeting human cytomegalovirus antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma.. Journal of Clinical Oncology. 42(16_suppl). 2039–2039. 4 indexed citations
3.
Hotchkiss, Kelly, Kristen A. Batich, Gerald E. Archer, et al.. (2021). IMMU-04. VACCINATING AGAINST NOVEL CYTOMEGALOVIRUS ANTIGENS IN GLIOBLASTOMA USING A PEPTIDE VACCINE IN COMBINATION WITH TEMOZOLOMIDE. Neuro-Oncology Advances. 3(Supplement_4). iv5–iv5. 1 indexed citations
4.
Gedeon, Patrick C., Teilo Schaller, Satish K. Chitneni, et al.. (2018). A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. Clinical Cancer Research. 24(15). 3611–3631. 38 indexed citations
5.
Riccione, Katherine A., Li-Zhen He, Peter E. Fecci, et al.. (2018). CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response. OncoImmunology. 7(12). e1502904–e1502904. 10 indexed citations
6.
Batich, Kristen A., Elizabeth A. Reap, Gary E. Archer, et al.. (2017). Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. Clinical Cancer Research. 23(8). 1898–1909. 242 indexed citations
7.
Dunn‐Pirio, Anastasie, Katherine B. Peters, Annick Desjardins, et al.. (2017). Tumor stem cell RNA-loaded dendritic cell vaccine for recurrent glioblastoma: a phase 1 trial (S41.004). Neurology. 88(16_supplement). 4 indexed citations
8.
Saraswathula, Anirudh, Elizabeth A. Reap, Bryan D. Choi, et al.. (2016). Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. Cancer Immunology Immunotherapy. 65(2). 205–211. 6 indexed citations
9.
Sánchez-Pérez, Luis, Carter M. Suryadevara, Bryan D. Choi, Elizabeth A. Reap, & John H. Sampson. (2014). Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy. OncoImmunology. 3(7). e944054–e944054. 16 indexed citations
10.
Sampson, John H., Bryan D. Choi, Luis Sánchez-Pérez, et al.. (2013). EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss. Clinical Cancer Research. 20(4). 972–984. 241 indexed citations
11.
Sánchez-Pérez, Luis, Bryan D. Choi, Elizabeth A. Reap, et al.. (2013). BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide. Cancer Immunology Immunotherapy. 62(6). 983–987. 13 indexed citations
12.
Morgan, Richard A., Laura A. Johnson, Jeremy L. Davis, et al.. (2012). Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma. Human Gene Therapy. 23(10). 1043–1053. 246 indexed citations
13.
Sampson, John H., Robert J. Schmittling, Gary E. Archer, et al.. (2012). A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma. PLoS ONE. 7(2). e31046–e31046. 91 indexed citations
14.
Reap, Elizabeth A., et al.. (2007). Evaluation of the immunogenicity of an alphavirus replicon particle vaccine expressing the SARS-CoV spike (S) glycoprotein in non-human primates (B191). The Journal of Immunology. 178(1_Supplement). LB40–LB40. 1 indexed citations
15.
Williamson, Carolyn, Lynn Morris, Maureen F. Maughan, et al.. (2003). Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development. AIDS Research and Human Retroviruses. 19(2). 133–144. 104 indexed citations
16.
Cohen, Philip L., Roberto Caricchio, Valsamma Abraham, et al.. (2002). Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase. The Journal of Experimental Medicine. 196(1). 135–140. 506 indexed citations breakdown →
17.
Reap, Elizabeth A., et al.. (1997). Markedly Diminished Radiation‐induced Lymphocyte Apoptosis in lpr Mice Suggests a Role for Fas in Eliminating Damaged Cells. Annals of the New York Academy of Sciences. 815(1). 116–118. 4 indexed citations
18.
Reap, Elizabeth A., et al.. (1996). MHC genes modify systemic autoimmune disease. The role of the I-E locus. The Journal of Immunology. 156(2). 812–817. 16 indexed citations
19.
20.
Costanzo‐Nordin, Maria Rosa, Elizabeth A. Reap, John B. OʼConnell, John A. Robinson, & Patrick J. Scanlon. (1985). A nonsteroid anti-inflammatory drug exacerbates coxsackie B3 murine myocarditis. Journal of the American College of Cardiology. 6(5). 1078–1082. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason A. Hackney Breakdown of academic impact, for papers by Hartmut Merz Breakdown of academic impact, for papers by Maria Raffaella Zocchi Breakdown of academic impact, for papers by Fabio Candotti Breakdown of academic impact, for papers by Richard J. Bram Breakdown of academic impact, for papers by Loise M. Francisco Breakdown of academic impact, for papers by Rudolf A. Manz Breakdown of academic impact, for papers by Bonnie Lyons Breakdown of academic impact, for papers by Bradley W. McIntyre Breakdown of academic impact, for papers by Lucia Gabriele
Rankless by CCL
2026